VYGR Notice: 6,458 Shares Scheduled for Sale

VYGR reports a planned sale of 6,458 common shares under Rule 144 tied to restricted stock vesting on 02/20/2026.

Rhea-AI Filing Summary

VYGR reports a planned sale of 6,458 common shares under Rule 144 tied to restricted stock vesting on 02/20/2026.

The filing also discloses prior dispositions by Robin E. Swartz in the past three months: 4,569 shares sold on 02/10/2026 for $17,598.87 and 3,882 shares sold on 02/18/2026 for $13,349.03. The planned sale is labeled as Issuer and linked to Compensation (restricted stock vesting).

Insights

Securities Compliance Counsel

Notice lists a Rule 144 sale of 6,458 shares after restricted stock vested.

The excerpt states the sale amount (6,458 shares) and the effective date 02/20/2026, with the method labeled as Issuer and Compensation. The filing identifies prior sales by Robin E. Swartz on 02/10/2026 (4,569 shares; $17,598.87) and 02/18/2026 (3,882 shares; $13,349.03).

Rule 144 notices are administrative disclosures of intended or effected resale under transfer restrictions. Timing and cash‑flow treatment for the planned sale are not specified beyond the vesting linkage; subsequent filings or transaction reports would show execution details.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the VYGR Form 144 report?

The report lists a planned resale of 6,458 common shares tied to restricted stock vesting on 02/20/2026. It also discloses two prior dispositions by Robin E. Swartz in February 2026.

Who executed recent share sales reported in the filing?

Robin E. Swartz is shown as the seller of 4,569 shares on 02/10/2026 and 3,882 shares on 02/18/2026, with the amounts and proceeds specified in the excerpt.

How much cash did the February 2026 sales generate?

The excerpt shows proceeds of $17,598.87 for 4,569 shares on 02/10/2026 and $13,349.03 for 3,882 shares on 02/18/2026, as reported in the filing.

Why is the planned sale labeled 'Issuer' and 'Compensation'?

The filing ties the 6,458-share planned sale to restricted stock vesting, indicating the shares arise from compensation. The excerpt labels the method as Issuer and the reason as Compensation.

Does this filing show who will receive the sale proceeds?

The excerpt does not state proceeds recipients. It lists the sale method as Issuer and links the planned sale to restricted stock vesting; cash‑flow recipients are not specified in the provided text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/24/2026 - 05:10 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001909636
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Voyager Therapeutics, Inc.
SEC File Number	001-37625
Address of Issuer	75 HAYDEN AVENUE LEXINGTON MASSACHUSETTS 02421
Phone	857-259-5340
Name of Person for Whose Account the Securities are To Be Sold	Swartz Robin
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	6458	24335.04	55600084	02/24/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/20/2026	Restricted Stock Vesting	Issuer			6458	02/20/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Robin E. Swartz 75 Hayden Avenue Lexington MA 02421	Common	02/10/2026	4569	17598.87
Robin E. Swartz 75 Hayden Avenue Lexington MA 02421	Common	02/18/2026	3882	13349.03

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	02/24/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Robin E. Swartz
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)